[HTML][HTML] Leveraging Tumor Mutation Profiles to Forecast Immune Checkpoint Blockade Resistance in Melanoma, Lung, Head and Neck, Bladder and Renal Cancers

G Mestrallet - Onco, 2024‏ - mdpi.com
Immune checkpoint blockade (ICB), radiotherapy, chemotherapy and surgery are currently
used as therapeutic strategies against melanoma, lung, bladder and renal cancers, but their …

[HTML][HTML] Onco: Covering the Field of Cancer Research and Cancer Therapies in 2024

CN Baxevanis, M Goulielmaki, OE Tsitsilonis… - Onco, 2025‏ - mdpi.com
The year of 2024 was successful regarding the scientific performance of Onco. This is
justified by the high scientific quality of the papers published in this journal, which covered a …

[HTML][HTML] Fraction of Genome Altered, Age, Microsatellite Instability Score, Tumor Mutational Burden, Cancer Type, Metastasis Status, and Choice of Cancer Therapy …

G Mestrallet - Onco, 2025‏ - mdpi.com
Abstract Background/Objectives: The accurate prediction of overall survival (OS) in cancer
patients is crucial for personalized treatment strategies. Methods: In this study, we …